The journal provides an open access forum for the publication of research, perspectives, and letters relating to the science, engineering, physics, and clinical application of thermal energy-based disease treatment.
Authors to the International Journal of Hyperthermia can benefit from a robust single-blind peer review process, fast publication times, indexing in PubMed and Scopus, and the dissemination of their research to an international audience.
Submitted manuscripts will be considered for publication in one of the following categories: Research & Clinical, Invited Reviews, Clinical Case Reports, Rapid Communications, and Letters.
Clinical Studies:
Manuscripts focused on disease treatment in clinical settings, including clinical trials and case studies that involve either human or animal patients.
Applications can encompass therapeutic thermal energy treatment or disease alone or in combination with other clinical modalities such as:
• Radiation;
• Chemotherapy;
• Radio-chemotherapy;
• Targeted agents;
• Immune modulators;
• Treatment optimization.
Studies can describe the whole both, regional or local treatment, practical considerations in therapy, and the physiological effects of heat or cold stress.
Manuscripts may also focus on clinical testing of methods specific to technologies such as RF or MW-heating, HIPEC, HIFU, HILP, cryotherapy, and ‘nano’-thermal or ‘nano’-drug delivery technologies.
Biological Studies:
Manuscripts focused on biological, biochemical, anatomical or physiological studies of a basic or preclinical nature using basic biochemical, cell, animal, or computational models.
Studies may focus on a combination of:
• Mechanisms of heat (cold) stress or heat (cold) shock;
• Thermal response and injury;
• Thermotolerance and modification of thermal response;
• Heat treatment in combination with other modalities;
• Effects on normal and diseased cells and tissues;
• Immunological and physiological effects;
• Toxicity and drug delivery;
• Gene therapy;
• Nanotechnology and nanomedicine;
• Tumor microenvironments.
Physics and Engineering:
Manuscripts devoted to the development of technologies and strategies for energy delivery and control, with an end goal to effect specific biologic responses leading to therapeutic outcomes.
Studies may focus on:
• Development of modalities and technology of therapy delivery, imaging, temperature management, and treatment monitoring and verification;
• The development of new technology systems or architectures;
• Advances in energy systems to produce tissue heating or cooling, or temperature monitoring and validation;
• Energy modalities and equipment development that controls tissue temperature regulation above and below physiological ranges, including: ultrasound, microwave, laser, EM, RF, UV, nanotechnology, and cryogenic systems.
We also accept studies which examine methods of measuring and modelling:
• Whole-body, regional, and local hyperthermia via computational means;
• Temperature distribution;
• The performance and evaluation of equipment;
• Safety and protection;
• Thermal dosimetry;
• Invasive and non-invasive thermometry and treatment verification;
• Calibration;
• Data acquisition and system control.
Publication Charges
There are no submission fee for this journal. However, there is a standard article publishing charge (APC) for this journal upon acceptance. Depending on your location, these charges may be subject to local taxes. The article publishing charge (APC) for the International Journal of Hyperthermia is $1,950 / £1,500 / €1,725.
Visit the Instructions for Authors page for detailed submission instructions.
Publication office: Taylor & Francis, Group, 530 Walnut Street, Suite 850, Philadelphia, PA 19106.
